Diffuse parenchymal drug related lung disease: report of a series

M. Romagnoli, M. Chilosi, G. L. Casoni, C. Bigliazzi, C. Gurioli, P. Vailati, M. Zompatori, L. Serra, V. Poletti (Forlì, Verona, Pordenone, Parma, Italy)

Source: Annual Congress 2006 - Interstial lung diseases
Session: Interstial lung diseases
Session type: Poster Discussion
Number: 4761
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Romagnoli, M. Chilosi, G. L. Casoni, C. Bigliazzi, C. Gurioli, P. Vailati, M. Zompatori, L. Serra, V. Poletti (Forlì, Verona, Pordenone, Parma, Italy). Diffuse parenchymal drug related lung disease: report of a series. Eur Respir J 2006; 28: Suppl. 50, 4761

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diffuse parenchymal lung disease: a different perspective
Source: ISSN=ISSN 1810-6838, ISBN=, page=240
Year: 2008

Neurofibromatosis-associated lung disease: a case series and literature review
Source: Eur Respir J 2007; 29: 210-214
Year: 2007



Diffuse parenchymal lung disease
Source: International Congress 2016 – Clinical year in review
Year: 2016


Diffuse parenchymal lung disease
Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017
Year: 2017



An unusual case of diffuse pulmonary meningotheliomatosis accompanying with cystic lung disease
Source: International Congress 2019 – Interstitial lung diseases?
Year: 2019

Interstitial lung diseases: course report
Source: Breathe, 15 (4) 270; 10.1183/20734735.0259-2019
Year: 2019



Interstitial lung diseases: course report
Source: Breathe, 14 (3) 184; 10.1183/20734735.019718
Year: 2018



Interstitial lung diseases: course report
Source: Breathe 2016; 12: 213-215
Year: 2016


Update on diffuse parenchymal lung disease
Source: Eur Respir Rev 2009; 19: 97-108
Year: 2010


Interstitial lung disease: ?course report
Source: Breathe, 16 (3) 200075; 10.1183/20734735.0075-2020
Year: 2020



A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Tracheobronchial amyloidosis mimicking lung cancer: a case report
Source: Eur Respir J 2004; 24: Suppl. 48, 532s
Year: 2004

A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2014 – ILDs 1
Year: 2014


Diffuse parenchymal lung diseases
Source: ERS Skills Course 2016
Year: 2016

Diffuse parenchymal lung diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Diffuse parenchymal lung diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Diffuse parenchymal lung diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Clinical case on ILD: a pulmonary case with many faces: not only interstitium
Source: Annual Congress 2007 - Clinical Grand Round: an interactive session
Year: 2007